Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 131 results
Author [ Title(Desc)] Year
Filters: Author is Fisher, Brian T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Lehrnbecher T, Fisher BT, Phillips B, et al. "Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients." J. Clin. Oncol.. 2020:JCO2000158.
Li Y, Newton JG, Getz KD, et al. "Comparable on-therapy mortality and supportive care requirements in Black and White patients following initial induction for pediatric acute myeloid leukemia." Pediatr Blood Cancer. 2018:e27583.
Chiotos K, Vendetti N, Zaoutis TE, et al. "Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12)." J. Antimicrob. Chemother.. 2016;71(12):3536-3539.
Fisher BT, Zaoutis TE, Xiao R, et al. "Comparative Effectiveness of Echinocandins vs Triazoles or Amphotericin B Formulations as Initial Directed Therapy for Invasive Candidiasis in Children and Adolescents." J Pediatric Infect Dis Soc. 2021.
Vendetti N, Bryan M, Zaoutis TE, Damianos A, Fisher BT. "Comparative effectiveness of fungicidal vs. fungistatic therapies for the treatment of paediatric candidaemia." Mycoses. 2016;59(3):173-8.
Miller TP, Troxel AB, Li Y, et al. "Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(7):1184-9.
Miller TP, Getz KD, Kavcic M, et al. "A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology Group." Leuk. Lymphoma. 2016:1-8.
Getz KD, Li Y, Alonzo TA, et al. "Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group." Pediatr Blood Cancer. 2015;62(10):1775-81.
Getz KD, Miller TP, Seif AE, et al. "A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropenia." Cancer Med. 2015;4(9):1356-64.
Savla JJ, Fisher BT, Faerber JA, Huang Y-SV, Mercer-Rosa L. "Complete Versus Staged Repair for Neonates With Tetralogy of Fallot: Establishment and Validation of a Cohort of 2235 Patients Using Detailed Surgery Sequence Review of Health Care Administrative Data." Med Care. 2017.
Winestone LE, Getz KD, Miller TP, et al. "Complications preceding early deaths in Black and White children with acute myeloid leukemia." Pediatr Blood Cancer. 2017.
DiNofia AM, Seif AE, Devidas M, et al. "Cost comparison by treatment arm and center-level variations in cost and inpatient days on the phase III high-risk B acute lymphoblastic leukemia trial AALL0232." Cancer Med. 2018;7(1):3-12.
Downes KJ, Laskin BL, Fisher BT. "The Cost of Vancomycin and Piperacillin/Tazobactam Treatment-Reply." JAMA Pediatr. 2018.
Citrin R, Horowitz JP, Reilly AF, et al. "Creation of a pediatric mature B-cell non-Hodgkin lymphoma cohort within the Pediatric Health Information System Database." PLoS ONE. 2017;12(10):e0186960.

Pages